Cervical cancer is emerging as a significant health crisis in Canada, with medical experts advocating for immediate government intervention to avert a looming public health disaster. During a press conference held on Wednesday by the Society of Gynecologic Oncology of Canada in Ottawa, specialists highlighted alarming statistics and urged for a national shift in policy to combat this preventable disease effectively.
A Growing Health Crisis
Dr. Shannon Salvador, president of the Society, denounced the current situation as a “silent national health crisis”. She pointed out that in 2025, approximately 1,650 Canadians were expected to receive a cervical cancer diagnosis, with 430 fatalities attributed to the disease—deaths that could be avoided with timely intervention.
Despite the federal government’s commitment in July 2025 to eliminate cervical cancer as a public health issue by 2040, many believe that current strategies are falling short. Dr. Salvador remarked, “While advancements in modern medicine are celebrated, the reality is that we are witnessing a troubling outlier in cervical cancer rates.”
Vaccination and Screening Shortfalls
The reliance on traditional Pap testing has proved insufficient. Dr. Salvador noted that Canada has seen a stagnation in the uptake of the human papillomavirus (HPV) vaccine, which is crucial for preventing cervical cancer. Currently, the vaccine completion rate stands at only 64%, a figure she described as “far below the target needed for elimination.”
“This statistic is not just a medical failure; it is a policy failure,” Dr. Salvador asserted, calling for a re-evaluation of existing health policies to better address the issue.
In response to these challenges, the Society of Gynecologic Oncology is advocating for a nationwide transition to HPV DNA testing as a primary screening method. They are also pushing for the introduction of self-collection kits, which would enable individuals to collect samples in the privacy of their own homes, thus reducing barriers to access.
Addressing Inequities in Healthcare
Dr. Sarah Kean, the provincial lead for cervical cancer in Manitoba, emphasised that the burden of cervical cancer is disproportionately borne by Indigenous women, who are often diagnosed at later stages and face worse outcomes. This disparity is attributed not to biological factors but rather to systemic barriers, including limited access to healthcare resources, geographic isolation, and the enduring impacts of colonial practices.
“Indigenous women are diagnosed at higher rates, with more advanced disease, and they experience worse outcomes. This is not due to biology,” Dr. Kean stated. She called for universal access to HPV screening and urged the federal government to support comprehensive legislative measures aimed at addressing these inequalities.
The Financial Implications
The cost to the Canadian healthcare system for treating cervical cancer reached an estimated $132 million in 2024. In stark contrast, the expenditure necessary to screen eligible Canadians was projected at $106 million over five years. This discrepancy highlights the potential for preventive measures to alleviate the financial burden of treatment by focusing on early detection and intervention.
Despite the World Health Organization’s global strategy to eliminate cervical cancer, recent reports indicate that progress has stalled. The Canadian Cancer Society revealed that while cervical cancer rates were declining between 1984 and 2005, the period from 2005 to 2021 saw a minimal decrease, suggesting a worrying trend that requires urgent attention.
Why it Matters
The rising rates of cervical cancer in Canada underscore an urgent public health challenge that demands immediate action. With a clear path toward prevention through vaccination and screening, the nation has an opportunity to turn the tide against this disease. Addressing the systemic barriers faced by marginalized communities is not just a matter of healthcare equity; it is essential for improving the overall health outcomes of all Canadians. The collective responsibility now lies with both policymakers and healthcare providers to implement effective strategies that ensure no one falls through the cracks of our fragmented healthcare system.
